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ABSTRACT
Objective: To evaluate the efficacy of peripheral
intravenous (IV) cannula site joint immobilisation by splint
application on functional duration of peripheral IV cannula
in neonates.
Design: Randomised controlled trial.
Setting: Neonatal intensive care unit of a tertiary care
hospital.
Participants: Neonates requiring continuous IV infusion
for an expected duration of more than or equal to
72 hours.
Intervention: Eligible cannulations were randomised to
either ‘‘splint’’ or ‘‘no-splint’’ group. In the splint group, a
cardboard splint was used to immobilise the joint at
peripheral IV cannula site. No attempt was made to
immobilise the limb in the no-splint group.
Outcome measure: Functional duration of a peripheral IV
cannula measured as interval from time of insertion to the
development of predefined sign of removal (extravasation,
blockage, inflammation).
Results: A total of 69 peripheral IV cannulations in 54
neonates were randomised to either the splint (n = 33) or
no-splint group (n = 36). Both groups were comparable in
birth weight, gestation, site of cannulation and nature of
fluids administered. Mean functional duration of cannula
was lesser in the splint group compared to the no-splint
group (h; 23.5 (SD15.9) vs 26.9 (SD15.5), mean
difference: 23.3 h, 95% CI 211.02 to 4.3 h) although
the difference was not statistically significant (p = 0.38).
Extravasation at cannula site was found be the
commonest indication for cannula removal in both the
groups (84% vs 76.5%).
Conclusion: Joint immobilisation with splint at cannula
site did not improve the functional duration of peripheral
IV cannula.
Neonates admitted to neonatal intensive care unit
(NICU) routinely undergo peripheral venous can-
nulation for administration of intravenous (IV)
fluids and drugs. This often requires multiple
peripheral venous cannulations to provide fluids
and drugs for prolonged periods. Multiple cannula-
tions expose the vulnerable newborns to repeated
painful and stressful experiences as well as the risk
of infection, which might result in adverse effect
on health and long-term neurodevelopmental out-
come.1 Measures to prolong the functional dura-
tion of a peripheral IV cannula may reduce the
number of cannulation attempts and save neonates
from pain and stress, as well as reduce the risk of
infection. Newer cannulae are soft, flexible and
easy to insert and last longer compared to scalp
vein needles used in the past.2
Polytetrafluorethylene catheters are found to
remain functional three times longer than steel
needles used in the past with no apparent increase
in complications.3 Splinting to immobilise the limb
is one traditionally used method to prolong the
functional duration of these cannulae. It is not
known whether the application of a splint is of any
benefit in prolonging the functional duration of
these newer polytetrafluorethylene cannulae in
newborn populations. The present study was
designed to study the efficacy of splinting the
joint on the functional duration of peripheral IV
cannula in neonates requiring continuous IV
infusion.
We hypothesised that in neonates, splinting to
immobilise the limb at cannulation site would
prolong the functional duration of peripheral IV
cannula as compared to no immobilisation.
METHODS AND SETTING
Study was conducted as a randomised controlled
trial in neonatal intensive care unit (NICU) of a
tertiary care hospital. All preterm and term
neonates admitted in the NICU and anticipated
to require peripheral continuous IV infusion for an
expected period of >72 hours were eligible for
enrolment into the study. Neonates with major
congenital malformations were excluded. An eligi-
ble cannulation was defined as one of the first
three successful cannulations performed in eligible
neonates with cannula being inserted over one of
the four major joints, that is, wrist, elbow, knee or
ankle. Eligible and successful cannulations were
randomised to ‘‘splint’’ or ‘‘no-splint’’ groups. A
neonate could be enrolled more than once with
each eligible cannulation being randomised inde-
pendent of group allocation of previous cannula-
tion. Allocation of group was done by
randomisation. A random number sequence was
generated in a fixed block size of four each using a
What is already known on this topic
c Splinting a peripheral cannula that overlies a
joint is a common practice.
c The efficacy of this practice has never been
formally tested.
What this study adds
c There is no role for immobilising the limb with a
splint to prolong the functional duration of
peripheral intravenous cannulae in neonates.
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web-based random number generator. The random codes were
kept in serially numbered, opaque and sealed, identical
envelopes.
Identical procedure for cannula insertion and fixation was
used in both of the groups. Senior (neonatology training
fellows) and junior (paediatric residents) residents were
responsible for IV cannulation, while nurses assisted them in
fixing the cannula. Twenty-four gauge peripheral IV cannulae
(BD Neoflon, Becton Dickinson India Pvt. Ltd, Haryana, India)
supplied by the hospital were used for cannulation in all
neonates. Prior to the onset of the study, all healthcare
personnel involved in insertion and fixation of cannula in the
NICU were provided with instructions on the technique of
insertion and fixation of peripheral IV cannulae at various
joints. In the splint group, a splint made up of cotton and gauze
piece rolled over a hard cardboard piece was applied to the limb
immediately after fixing the cannula, as per the standardised
method, to prevent movement at the underlying joint.
Dimensions of the splints used were standardised as length
extending two inches on either side of the joint and width equal
to the width of the limb just proximal to the joint. In the no-
splint group the cannula was fixed, as per the standardised
method, and no effort was made to immobilise the joint. IV
fluids and drugs were administered using syringe infusion
pumps. After insertion and fixation, the cannula site was
monitored for development of sign of removal every 2 hours by
a resident or nurse on-duty. The sign of removal was defined as
presence of any one of the following:
c extravasation—characterised by swelling and oedema at the
cannula site
c blockage—indicated by high occlusion on infusion pump
c inflammation—characterised by swelling, redness and raised
temperature or tenderness over the cannula site.
If a baby no longer needed the cannula for a clinical indication
or no longer required continuous IV fluids, time to such an
event was noted. The functional duration of the cannula was
measured in hours, from time of insertion to time of
development of a sign of removal. As part of the clinical
protocol we did not use intermittent flushes or heparin lock to
maintain patency of IV cannula. We also avoided using muscle
relaxants or sedatives.
Mean functional duration of the peripheral IV cannula without
splint was found to be 48 hours (SD36 hours) in our NICU in a
pilot study (unpublished). To detect a difference of at least 24 h
with 80% power and 95% confidence interval (CI), we needed to
enrol 36 peripheral IV cannulations. The protocol was cleared by
the Institutional Ethics Committee. Informed written consent
was taken from one of parents of enrolled newborns.
All baseline and outcome data were recorded prospectively in
a predesigned and pretested data collection form. The data were
checked for completion, consistency and accuracy. Data were
analysed using the software Stata V.9.1. Group characteristics
were compared with x2 test and two-sample t test for discrete
and continuous variables respectively. A p value of ,0.05 was
taken as statistically significant. Analysis was by intention to
treat.
RESULTS
The study was conducted from November 2006 to July 2007.
Figure 1 provides the participant flow as per CONSORT
guidelines.4 A total of 387 neonates were admitted to NICU
during the study period. Of these, 54 neonates were enrolled
into the study and 69 cannulations performed on these neonates
were included into the study. Out of the 69 cannulations
enrolled, one cannulation in each group was excluded from
analysis as the cannulation site was not over a joint. One
Figure 1 Study flow chart. *Up to three
successful cannulations in each eligible
neonate could be enrolled and
randomised.
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neonate in the no-splint group was transferred out of NICU
before development of signs of removal and could not be
monitored further. The cannula was functional until 54.5 hours
after insertion.
The groups were comparable with respect to gestation, birth
weight, mode of delivery and the site of cannulation (table 1).
There was no difference between the groups in the nature of
fluid administered, person inserting the cannula and serial
number of cannulation randomised to the group.
Mean functional duration of the peripheral IV cannula was
less in the splint group compared to the no-splint group,
although the difference was not statistically significant (hours;
23.5 (SD5.9) vs 26.9 (SD15.5); mean difference 23.3, 95% CI:
211.0 to 4.3; p = 0.38). This difference was more in neonates
with gestational age ,30 wks, however the sample size in this
group of neonate is too small to arrive at any conclusion.
Extravasation at cannula site was the most common cause of
cannula removal in both the groups (84% vs 76.5% of cases).
Complications like skin damage and allergic reaction related to
use of splint were not observed.
DISCUSSION
The usefulness of splint application to immobilise the joint after
peripheral IV cannula insertion has remained unresolved as this
issue has never been studied in a controlled trial. The present
study, therefore, attempts to resolve the issue of the usefulness of
splint in prolonging the functional duration of a peripherally
inserted IV cannula through a randomised controlled trial. Johnson
et al5 surveyed prospectively peripheral IV cannula use in a
neonatal intensive care unit to ascertain the rate of complications
and the factors influencing the life span of an IV cannula. During a
three-month period in which 199 IV cannulae were inserted in 69
patients, only two significant infiltrations (1%) were observed in
more than 5000 hours of IV therapy. None of the factors studied,
including weight, age, type and rate of fluid administration, and
type of medication (except pancuronium bromide), had any
discernible effect on the functional life span of IV cannulae.
In another similar study Gupta et al6 studied variables
affecting life span of a peripheral IV cannula in a NICU of a
developing country. The median survival time of an IV cannula,
as expressed by Kaplan-Meir survival analysis, was 40 hours
(SE, 2.49; 95% CI, 35.12 to 44.88). Birth weight, gestation,
application of splint, fluid and glucose infusion rate, site of
cannulation and administration of antibiotics (ampicillin,
gentamicin, amikacin, vancomycin) phenobarbitone, blood
products, or calcium gluconate did not influence the median
life span of IV cannulae.
In present study, mean functional duration of peripheral IV
cannulae in both groups was less than as reported by Gupta et
al.6 This is probably due to the enrolment of a greater number of
premature babies in the present study. Splint application was
found to be associated with a decrease in functional duration of
a peripheral IV cannula, although the difference was not
statistically significant. This effect is more pronounced in
neonates with lower gestational age (gestational age
,30 weeks); however, the number of subjects in this group
was too small to draw any conclusion. Extravasation at the
cannula site is found to be the commonest indication for
cannula removal. From these observations it can be hypothe-
sised that splint application may promote extravasation by
causing pressure on the draining veins via the adhesive tape used
for fixing the splint proximally. Infants with a lower gestational
age have immature thin walled veins with poor vascular tone,
predisposing them to greater risk of extravasation even with
slight external pressure. The type of fluid administered may also
affect the rate of extravasation. Irritant fluids may cause early
extravasations, however, there was no difference in the nature
of fluid administered in the two groups. Also, previous studies
have found no effect of type and rate of fluid administration on
functional life span of the peripheral IV cannula.5 6 The present
study addresses a common practice issue through a randomisa-
tion trial in NICU setting. Blinding of the observers monitoring
for signs of removal was not possible due to the nature of the
intervention, which might have introduced some bias.
In conclusion, it can be stated that application of a splint to
immobilise the joint while using a peripheral IV cannula does
not prolong the functional duration of the cannula.
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Table 1 Baseline characteristics of neonates enrolled in two groups
Baseline variable Splint group (n = 33) No-splint group (n = 36)
Gestation (wks) 32 (30–33) 33 (31–35)
Birth weight (g) 1226 (984–1511) 1131 (933–1352)
Mode of delivery
Caesarean 25 (77%) 31 (86%)
Other 8 (23%) 5 (14%)
Site of cannulation
Wrist 26 (79%) 26 (74%)
Others 7 (21%) 10 (26%)
Cannula inserter
Senior resident 19 (58%) 22 (63%)
Junior resident 12 (36%) 13 (37%)
Nurse 2 (6%) 0
Serial number of
cannulation
First 16 (49%) 25 (69%)
Second 11 (33%) 6 (17%)
Third 6 (18%) 5 (14%)
Type of IV fluid
10% dextrose 7 (23%) 14 (40%)
10% dextrose + calcium
gluconate
12 (39%) 13 (37%)
N/5 in 10% dextrose 1 (3%) 0
Parenteral nutrition 9 (29%) 6 (17%)
Others 2 (6.5%) 2 (6%)
Data expressed as median (inter-quartile range) or n (%).
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